Compound 5
Identifiers
- Canonical SMILES:
CNC(=O)c1ccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)cc1
- IUPAC name:
4-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N-methylbenzamide
- InChi:
InChI=1S/C23H27N3O4/c1-16-15-25(23(29)19-7-5-4-6-8-19)13-14-26(16)22(28)17(2)30-20-11-9-18(10-12-20)21(27)24-3/h4-12,16-17H,13-15H2,1-3H3,(H,24,27)/t16-,17-/m1/s1
- InChiKey:
GTKRGUHTQKGJJW-IAGOWNOFSA-N
External links
45485384 |
24635343 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 5.59 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 409.20 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 1.92 | |||
TPSA | 78.95 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6696 | Tiropramide | DB13091 | |
0.6514 | Fipexide | DB13790 | |
0.6304 | Bavisant | DB12299 | |
0.6250 | Itopride | DB04924 | |
0.6132 | Troxipide | DB13419 | |
0.6064 | Aniracetam | DB04599 | |
0.6000 | Trimethobenzamide | DB00662 | |
0.5941 | OTX-008 | DB13123 | |
0.5842 | 4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE | DB08608 | |
0.5796 | Bunaftine | DB13652 | |
0.5714 | Bephenium | DB13462 | |
0.5596 | Bezafibrate | DB01393 | |
0.5572 | 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE | DB06869 | |
0.5567 | Lacosamide | DB06218 | |
0.5464 | Moclobemide | DB01171 |